Henri Bayle
Company: NKILT Therapeutics
Job title: Chief Scientific Officer
Seminars:
What’s Next for Complex Bioengineering Approaches to Cell Therapy? 3:00 pm
Exploring novel engineering approaches for next-generation CAR constructs and current bottlenecks for current technologies Exploring the commercial potential of integrating CRISPR and synthetic biology to develop next-generation CAR-T products with enhanced efficacy and safety Investigating the future potential of multi-functional cell therapiesRead more
day: Conference Day Two